Search research articles
Contact Us
Filters
Showing results (161-170 of 326) with videos related to
Page
of 33
Sort By:
Cancer Treatment Reports
|
March 1, 1978
Phase II evaluation of pyrazofurin in patients with carcinoma of the lung
R J Gralla, V E Currie, R E Wittes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin
R M Navari, H G Kaplan, R J Gralla, et al.
Cancer Treatment Reports
|
August 1, 1979
Phase II trial of vindesine in patients with germ-cell tumors
T F Reynolds, D Vugrin, E Cvitkovic, et al.
AJNR. American Journal of Neuroradiology
|
December 19, 2009
In vivo evaluation of the Phenox CRC mechanical thrombectomy device in a swine model of acute vessel occlusion
P Mordasini, M Hiller, C Brekenfeld, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2016
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents
Karin Jordan, Alexandre Chan, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration
D R Gandara, F Roila, D Warr, et al.
AJNR. American Journal of Neuroradiology
|
June 1, 2013
In vitro and in vivo imaging characteristics assessment of polymeric coils compared with standard platinum coils for the treatment of intracranial aneurysms
P Mordasini, A K Kraehenbuehl, J V Byrne, et al.
The Oncologist
|
March 23, 2016
Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program
Matti Aapro, Paul J Hesketh, Karin Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1989
Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin
M G Kris, R J Gralla, L B Tyson, et al.
AJNR. American Journal of Neuroradiology
|
February 22, 2014
Impact of age and baseline NIHSS scores on clinical outcomes in the mechanical thrombectomy using solitaire FR in acute ischemic stroke study
M A Almekhlafi, A Davalos, A Bonafe, et al.
Page
of 33
Search research articles
Search
Showing results (161-170 of 326) with videos related to
Sort By:
Page
of 33
Cancer Treatment Reports
|
March 1, 1978
Phase II evaluation of pyrazofurin in patients with carcinoma of the lung
R J Gralla, V E Currie, R E Wittes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin
R M Navari, H G Kaplan, R J Gralla, et al.
Cancer Treatment Reports
|
August 1, 1979
Phase II trial of vindesine in patients with germ-cell tumors
T F Reynolds, D Vugrin, E Cvitkovic, et al.
AJNR. American Journal of Neuroradiology
|
December 19, 2009
In vivo evaluation of the Phenox CRC mechanical thrombectomy device in a swine model of acute vessel occlusion
P Mordasini, M Hiller, C Brekenfeld, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 10, 2016
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents
Karin Jordan, Alexandre Chan, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration
D R Gandara, F Roila, D Warr, et al.
AJNR. American Journal of Neuroradiology
|
June 1, 2013
In vitro and in vivo imaging characteristics assessment of polymeric coils compared with standard platinum coils for the treatment of intracranial aneurysms
P Mordasini, A K Kraehenbuehl, J V Byrne, et al.
The Oncologist
|
March 23, 2016
Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program
Matti Aapro, Paul J Hesketh, Karin Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1989
Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin
M G Kris, R J Gralla, L B Tyson, et al.
AJNR. American Journal of Neuroradiology
|
February 22, 2014
Impact of age and baseline NIHSS scores on clinical outcomes in the mechanical thrombectomy using solitaire FR in acute ischemic stroke study
M A Almekhlafi, A Davalos, A Bonafe, et al.
Page
of 33